Metabolic Tumor Volume Predicts for Recurrence and Death in Head-and-Neck Cancer

This publication has 29 references indexed in Scilit:

• Prediction of prognosis using standardized uptake value of 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas
  Radiotherapy and Oncology, 2008
• Prospective study of 18FDG‐PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA‐13 study
  Head & Neck, 2007
• Metabolic Tumor Burden Predicts for Disease Progression and Death in Lung Cancer
  International Journal of Radiation Oncology*Biology*Physics, 2007
• 2-[18F]-Fluoro-2-deoxy-d-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx
  European Journal of Surgical Oncology, 2007
• Multiagent Concurrent Chemoradiotherapy for Locoregionally Advanced Squamous Cell Head and Neck Cancer: Mature Results From a Single Institution
  Journal of Clinical Oncology, 2006
• Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
  New England Journal of Medicine, 2006
• An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
  Journal of Clinical Oncology, 2003
• Standardized Uptake Value of 2-[18F] Fluoro-2-Deoxy-D-Glucose in Predicting Outcome in Head and Neck Carcinomas Treated by Radiotherapy With or Without Chemotherapy
  Journal of Clinical Oncology, 2002
• Squamous Cell Carcinoma of the Oropharynx-An Analysis of Treatment Results in 289 Consecutive Patients
  Acta Oncologica, 2000
• Proportional hazards tests and diagnostics based on weighted residuals
  Biometrika, 1994